A marijuana derivative called cannabidiol, or CBD, has begun making its way into supplements and even into foods, a use that runs afoul of an FDA designation of the compound as a prescription drug. A Harvard Medical School associate professor says CBD’s tangled legal status may provide an opportunity not only to clear up its status, but to bring clarity to the entire supplements industry.